Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest nContact Inc. Stories

2013-01-25 08:23:08

MORRISVILLE, N.C., Jan. 25, 2013 /PRNewswire/ -- Innovations In Cardiac Rhythm Management published an article by Dr. H. Edward Garrett, Jr., MD of Baptist Memorial Hospital, Memphis, TN that evaluated nContact's unipolar epicardial ablation devices, the Numeris® and EPi-Sense® Coagulation Systems with VisiTrax®. The study purpose was to measure the ability of the device to create transmural epicardial lesions. During two chronic GLP preclinical studies performed at two sites,...

2012-05-10 02:31:51

MORRISVILLE, N.C., May 10, 2012 /PRNewswire/ -- Electrophysiology thought leaders gathered to discuss the significance of posterior ablation in the treatment of arrhythmias, with presentations highlighting the importance of isolating the posterior left atrium with an adjunctive epicardial treatment. The symposium was supported by nContact, Inc. and held in conjunction with Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, in Boston, MA, on the evening of May 8....

2012-05-02 02:27:55

MORRISVILLE, N.C., May 2, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced its technology will be included in an oral presentation during an abstract session and two poster presentations at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, May 9-12 in Boston, MA. nContact's Numeris® Coagulation System with VisiTrax® and EPi-Sense(TM) Coagulation System technology integrates suction, perfusion, and...

2012-03-27 02:27:20

MORRISVILLE, N.C., March 27, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced that CEO John Funkhouser spoke at the American College of Cardiology's (ACC) Cardiovascular Innovations Educational Forum in Chicago, IL, on the future of cardiac ablation under managed care. The theme of the talk was anticipated managed care requirements for the industry, and though the exact form they will take is uncertain, the presentation contained...

2012-02-23 07:01:00

MORRISVILLE, N.C., Feb. 23, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced that a new preclinical study examines a unique minimally invasive percutaneous approach to accessing the heart that may enable electrophysiologists (EPs) to perform epicardial ablation for ventricular tachycardia (VT). The study was published in the February 2012 issue of The Journal of Innovations in Cardiac Rhythm Management. In the study, "Creating...

2012-01-11 07:01:00

MORRISVILLE, N.C., Jan. 11, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced that its recently launched corporate website, www.ncontactinc.com, has won a 2011 Interactive Media Award for Best in Class Medical Site, presented by the nonprofit Interactive Media Council. The new website, designed by Studio 1440, has been recognized for excellence in design, development and implementation, through a competition of over 500...

2012-01-09 07:01:00

MORRISVILLE, N.C., Jan. 9, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced its technology will be presented by physicians in two posters at the 17th Annual International Boston Atrial Fibrillation Symposium, January 12-14 in Boston, Massachusetts. nContact will be showcasing its Numeris® Coagulation System with VisiTrax® and next generation EPi-Sense(TM) Coagulation System at its Boston AF Symposium booth #301....

2011-10-26 07:00:00

MORRISVILLE, N.C., Oct. 26, 2011 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, announced today the launch of its new corporate websites, www.ncontactinc.eu and www.ncontactinc.com. The design of the new corporate sites reflects the evolution of nContact's technology and the market for treating cardiac arrhythmias that affect millions of people worldwide. "The new websites are excellent educational references that highlight how our technology is...

2011-01-10 07:03:00

MORRISVILLE, N.C., Jan. 10, 2011 /PRNewswire/ -- nContact Surgical, Inc. (nContact), a cardiac ablation device manufacturer, announced today that it is changing the name under which it operates from nContact Surgical, Inc. to nContact, Inc. As the pioneer of interdisciplinary epicardial and endocardial cardiac ablation, the change represents the Company's further evolution towards closed chest approaches to treating common cardiac arrhythmias. "nContact's progressive technology and our...